Introduction
Surface Technologies
The NanoTite™Implant Family
The NanoTite Implant is the patented OSSEOTITE® dual-acid-etched surface,
which is then further treated with a deposition of nanometer scale crystals of
calcium phosphate. This is known as the Discrete Crystalline Deposition or
DCD® Process. The surface treatment is a discrete crystalline deposition on the
OSSEOTITE Surface, not a plasma sprayed coating.
NanoTite Surface at 20,000x
magnification
The synergistic effect of these two technologies, the OSSEOTITE Surface and the
DCD Process has demonstrated promising results in animal studies.* Because of
this synergistic effect, a more complex micro-surface is created. Preclinical
studies* demonstrated that the NanoTite Surface treatment, when compared to
OSSEOTITE Control Implants, significantly improved the rate and extent of
bone-to-implant contact, resulting in statistically significant enhanced integration.1,2
For all NanoTite Configurations, wherever there is the dual-acid-etched
OSSEOTITE Surface, the DCD nano-scale calcium phosphate has been applied.
1. Mendes VC, Davies JE†. Discrete calcium phosphate nanocrystals enhance osteoconduction on titanium-based implant surfaces. Canadian Biomaterials Society.
25th Annual Meeting. May 26-28, 2006. Calgary, Alberta, Canada.
2. Mendes VC, Davies JE†. Discrete calcium phosphate nanocrystals render titanium surfaces bone-bonding. Int J Oral Maxillofac Implant. 2007;22:484.
*Pre-clinical studies are not necessarily indicative of clinical results.
The OSSEOTITE® Implant Family
The OSSEOTITE Implant features the
patented dual-acid-etched
surface that is optimal for improving the clot/implant attachment, which may
increase platelet activation and red blood cell (rbc) agglomeration.1
OSSEOTITE Surface at 20,000x
magnification
For more than 15 years, with documentation from numerous global multicenter
clinical evaluations,2-9 the OSSEOTITE Surface has proven to be one of the most
predictable and well-researched surfaces ever. Clinical studies on the OSSEOTITE
Surface document the benefits of increased contact osteogenesis, especially in poor
quality bone.10
1. Park JY, Davies JE†. Red Blood Cell and Platelet Interactions with Titanium Implant Surfaces. Clinical